Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression
- 1 January 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 351 (9097) , 187-188
- https://doi.org/10.1016/s0140-6736(05)78209-x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- IMMUNOGENETIC FACTORS IN HPV‐ASSOCIATED CERVICAL CANCER: INFLUENCE ON DISEASE PROGRESSIONInternational Journal of Immunogenetics, 1996
- A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancerThe Lancet, 1996
- Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expressionBritish Journal of Cancer, 1995
- The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 monthsInternational Journal of Cancer, 1995
- A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.The Journal of Experimental Medicine, 1993